PACAP-27 vs Insulin Aspart

Head-to-head comparison of PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPACAP-27Insulin Aspart
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NamePituitary Adenylate Cyclase-Activating Polypeptide-27Insulin aspart (B28-Asp human insulin analog)
Molecular Weight3158 Da5825.8 Da
Half-LifeminutesAbout 1-3 hours
Amino Acids2751
Typical DoseResearch-only: 0.1-1 nmol/kg0.05-0.2 U/kg per meal
RouteIntraperitoneal/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count22011000
Research StatusPre-clinicalApproved

PACAP-27 Benefits

  • anti-apoptotic signaling
  • insulin secretagogue effect
  • reduced ER stress
  • islet cytoprotection

Insulin Aspart Benefits

  • Fast post-meal glucose lowering
  • Predictable onset
  • Flexible mealtime administration
  • Compatible with pump therapy

PACAP-27 Dosing

0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing

Insulin Aspart Dosing

Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens

PACAP-27 Side Effects

  • flushing
  • hypotension at high exposure
  • headache

Insulin Aspart Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

PACAP-27

PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.

Insulin Aspart

Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

PACAP-27 stacks with:

GLP-1 analogsDPP-4 inhibitorsdiet and exercise

Insulin Aspart stacks with:

Insulin GlargineInsulin Degludec
neuropeptidebeta-cell protectioncAMP signalingrapid-acting insulinmeal coveragepump-compatible